Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02477124 · ClinicalTrials.gov registry record · NA
A See and Treat Paradigm for Cervical Pre-cancer
A NA study, sponsored by Duke University.
- Terminated
- Registry status
- NA
- Development phase
- 514
- Enrollment target
NCT02477124 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 514 participants.
The verdict
NCT02477124, a NA study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- NA
- Development phase
- 514 participants
- Enrollment target
Study Summary
The purpose of this study is to see if the transvaginal colposcope produces similar results to colposcopy for the screening of cervical cancer. In this study the investigators are using an investigational device called the transvaginal colposcope. The word investigational means that the device is still being tested in research studies and is not approved by the U.S. Food and Drug Administration (FDA).
Interventions
- DEVICE transvaginal digital colposcope (TVDC)
- OTHER Standard of care screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 514 participants |
| Start Date | 2015-09 |
| Est. Completion | 2020-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02477124
The ClinicalTrials.gov registry entry for NCT02477124 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 514 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which transvaginal digital colposcope (TVDC) is the first listed.
NCT02477124 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02477124 about?
NCT02477124 is a clinical study titled "A See and Treat Paradigm for Cervical Pre-cancer". The purpose of this study is to see if the transvaginal colposcope produces similar results to colposcopy for the screening of cervical cancer. In this study the investigators are using an investigational device called the transvaginal colposcope. The word investigational means that the device is st...
What is the current status of trial NCT02477124?
This trial is currently terminated. It is a NA study. The enrollment target is 514 participants. The study started on 2015-09. Estimated completion is 2020-03.
What interventions are being tested in trial NCT02477124?
The interventions under investigation include: transvaginal digital colposcope (TVDC) (DEVICE), Standard of care screening (OTHER).
Who is sponsoring clinical trial NCT02477124?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.